RAVAGALIMAB

UNII:	YGF9TW3QZJ
Formula:
Preferred Substance Name:	RAVAGALIMAB

2050816-56-1
ABBV-323
IMMUNOGLOBULIN G1, (ANTI-HUMAN CD19 (ANTIGEN)) (HUMANIZED CLONE RB4V1.2 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED CLONE RB4V1.2 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD40 ANTIGEN) (HUMANIZED MOUSE MONOCLONAL PR-1629977 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL PR-1629977 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 5 (B-CELL SURFACE ANTIGEN CD40))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-446) (HUMANIZED VH (HOMO SAPIENS IGHV3-48*01 (90%) (IGHD)-IGHJ6*01) (8.8.9) (1-116)-HOMO SAPIENS IGHG1*03 (CH1(R97>K(213)), CH2(L4>A(233),L5>A(234)), (CH3(M88>L(427))) (117-446)) (219-220')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-220') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV4-1*01 (89%) IGKJ2*01)(12.3.9) (1'-113')-HOMO SAPIENS IGKC*01 (114'-220')), DIMER (225-225'':228-228'')-BISDISULFIDE
PR-1629977
RAVAGALIMAB [INN]
RAVAGALIMAB [USAN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RAVAGALIMAB

Synonyms and Mappings

Resources